Abstract
Background Artificial intelligence (AI) technologies can help solve the significant problem of missed findings in radiology studies. An important issue is assessing the economic benefits of implementing AI.
Aim to evaluate the frequency of missed pathologies detection and the economic potential of AI technology for chest CT, validated by expert radiologists, compared with radiologists without access to AI in a private medical center.
Methods An observational, single-center retrospective study was conducted. The study included chest CTs without IV contrast performed from 01.06.2022 to 31.07.2022 in "Yauza Hospital" LLC, Moscow. The CTs were processed using a complex AI algorithm for ten pathologies: pulmonary infiltrates, typical for viral pneumonia (COVID-19 in pandemic conditions); lung nodules; pleural effusion; pulmonary emphysema; thoracic aortic dilatation; pulmonary trunk dilatation; coronary artery calcification; adrenal hyperplasia; osteoporosis (vertebral body height and density changes). Two experts analyzed CTs and compared results with AI. Further routing was determined according to clinical guidelines for all findings initially detected and missed by radiologists. The lost potential revenue (LPR) was calculated for each patient according to the hospital price list.
Results From the final 160 CTs, the AI identified 90 studies (56%) with pathologies, of which 81 studies (51%) were missing at least one pathology in the report. The "second-stage" LPR for all pathologies from 81 patients was RUB 2,847,760 ($37,251 or CNY 256,218). LPR only for those pathologies missed by radiologists but detected by AI was RUB 2,065,360 ($27,017 or CNY 185,824).
Conclusion Using AI for chest CTs as an "assistant" to the radiologist can significantly reduce the number of missed abnormalities. AI usage can bring 3.6 times more benefits compared to the standard model without AI. The use of complex AI for chest CT can be cost-effective.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Independent Ethics Committee of the Moscow Regional Branch of the Russian Society of Roentgenologists and Radiologists gave ethical approval for this work on 01.03.2023.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Figure 1 revised; added figure 2.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
List of abbreviations
- AI
- - artificial intelligence
- CI
- - confidence interval
- COPD
- - chronic obstructive pulmonary disease
- CT
- - computed tomography
- CVD
- - cardiovascular disease
- Dataset
- - a set of data, a collection of logical records
- ICD-10
- - International Classification of Diseases 10th revision
- LCS
- - Lung Cancer Screening
- LDCT
- - low dose computed tomography
- LPR
- - lost potential revenue
- MILD
- - Multicentric Italian Lung Detection
- MRI
- - magnetic resonance imaging
- NLST
- - National Lung Screening Trial
- PACS-RIS
- - Picture Archiving and Communication System Radiology information systems
